World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
47
Citations
11149
World Ranking
4485
National Ranking
178

Toos Daemen publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Toos Daemen sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 218 publications — 41st percentile

41% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Toos Daemen D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Toos Daemen sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 47 D-Index — 9th percentile

9% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Toos Daemen is affiliated with the University Medical Center Groningen in the Netherlands. Their research spans multiple fields, mainly focusing on Biochemistry, Genetics and Molecular Biology, with 33 publications, as well as Medicine, with 23 publications. Within these domains, Daemen's subfields of study include Molecular Biology, Genetics, Immunology, Epidemiology, and Oncology.

Their work centers around several key topics that have shaped Daemen's publication record. These topics are:

  • Virus-based gene therapy research
  • CAR-T cell therapy research
  • Immune cells in cancer
  • Cancer, Hypoxia, and Metabolism
  • RNA Interference and Gene Delivery
  • Viral Infectious Diseases and Gene Expression in Insects
  • Animal Virus Infections Studies

Daemen has contributed papers to a variety of scientific venues. The most frequent publication platforms include:

  • Vaccines
  • Scientific Reports
  • iScience
  • bioRxiv (Cold Spring Harbor Laboratory)
  • Molecular Therapy

Among recent papers authored or co-authored by Daemen, the following are notable:

  • "First-in-Human Phase I Clinical Trial of an SFV-Based RNA Replicon Cancer Vaccine against HPV-Induced Cancers," 2020, Molecular Therapy
  • "Re-polarization of immunosuppressive macrophages to tumor-cytotoxic macrophages by repurposed metabolic drugs," 2021, OncoImmunology
  • "Resistance Mechanisms Influencing Oncolytic Virotherapy, a Systematic Analysis," 2021, Vaccines
  • "Therapeutic Vaccines and Cancer Immunotherapy," 2020, Vaccines
  • "Hepatitis C Virus Proteins Core and NS5A Are Highly Sensitive to Oxidative Stress-Induced Degradation after eIF2α/ATF4 Pathway Activation," 2020, Viruses

In their collaborations, Daemen frequently works with several co-authors, including:

  • Darshak Bhatt
  • Franz J. Weissing
  • Baukje Nynke Hoogeboom
  • Thijs Janzen
  • Annemarie Boerma

Best Publications

  • The prognostic influence of tumour-infiltrating lymphocytes in cancer: a systematic review with meta-analysis

    Marloes Gooden;de Truuske Bock;Ninke Leffers;Toos Daemen

  • Surface modification of nanoparticles to oppose uptake by the mononuclear phagocyte system

    Gert Storm;Sheila O. Belliot;Toos Daemen;Danilo D. Lasic

  • Liposomes in the Therapy of Infectious Disease and Cancer

    Toos Daemen;M Hardonk;J Koudstaal;W oosterhuis

  • Cells of the hepatic sinusoid

    Toos Daemen;J Koudstaal;GL Scherphof;M Hardonk

  • Prognostic significance of tumor-infiltrating T-lymphocytes in primary and metastatic lesions of advanced stage ovarian cancer.

    Ninke Leffers;Marloes J. M. Gooden;Renske A. de Jong;Baukje-Nynke Hoogeboom

  • A potential role of macrophage activation in the treatment of cancer.

    AH Klimp;de Elisabeth G. E. Vries;GL Scherphof;Toos Daemen

  • The virosome concept for influenza vaccines

    Anke Huckriede;Laura Bungener;Toon Stegmann;Toos Daemen

  • Myeloid derived suppressor cells—An overview of combat strategies to increase immunotherapy efficacy

    Oana Draghiciu;Joyce Lubbers;Hans W Nijman;Toos Daemen

  • Expression of Cyclooxygenase-2 and Inducible Nitric Oxide Synthase in Human Ovarian Tumors and Tumor-associated Macrophages

    Alida H. Klimp;Harry Hollema;Claudia Kempinga;Ate G. J. van der Zee

  • Liposomal doxorubicin-induced toxicity: depletion and impairment of phagocytic activity of liver macrophages

    Toos Daemen;Gert Hofstede;Marian T. Ten Kate;Irma A. J. M. Bakker-Woudenberg

  • Immunization with a P53 synthetic long peptide vaccine induces P53‐specific immune responses in ovarian cancer patients, a phase II trial

    Ninke Leffers;Annechien J. A. Lambeck;Marloes J. M. Gooden;Baukje-Nynke Hoogeboom

  • Virosome-mediated delivery of protein antigens to dendritic cells.

    Laura Bungener;Karine Serre;Liesbeth Bijl;Lee Leserman

  • Vaccination against Oncoproteins of HPV16 for Noninvasive Vulvar/Vaginal Lesions: Lesion Clearance Is Related to the Strength of the T-Cell Response

    Mariëtte I E van Poelgeest;Marij J P Welters;Renee Vermeij;Linda F M Stynenbosch

  • CD103+ tumor-infiltrating lymphocytes are tumor-reactive intraepithelial CD8+ T cells associated with prognostic benefit and therapy response in cervical cancer.

    Fenne L. Komdeur;Thalina M. Prins;Stephanie van de Wall;Annechien Plat

  • Frequencies and role of regulatory T cells in patients with (pre)malignant cervical neoplasia.

    Jeroen Visser;Hans Nijman;B.-N. Hoogenboom;P. Jager

  • Sunitinib depletes myeloid-derived suppressor cells and synergizes with a cancer vaccine to enhance antigen-specific immune responses and tumor eradication

    Oana Draghiciu;Hans W Nijman;Baukje Nynke Hoogeboom;Tjarko Meijerhof

  • Virosomes for antigen and DNA delivery

    Toos Daemen;Arjan de Mare;Laura Bungener;Jørgen de Jonge

  • Serum Cytokine Profiling as a Diagnostic and Prognostic Tool in Ovarian Cancer: A Potential Role for Interleukin 7

    Annechien J. A. Lambeck;Anne P. G. Crijns;Ninke Leffers;Wim J. Sluiter

  • Induction of cytotoxic T lymphocyte activity by fusion-active peptide-containing virosomes.

    Annemarie Arkema;Anke Huckriede;Pieter Schoen;Jan Wilschut

  • Virosome-mediated delivery of protein antigens in vivo: efficient induction of class I MHC-restricted cytotoxic T lymphocyte activity

    Laura Bungener;Anke Huckriede;Arjan de Mare;Jacqueline de Vries-Idema

  • Potentiation of a p53-SLP vaccine by cyclophosphamide in ovarian cancer: A single-arm phase II study

    Renee Vermeij;Ninke Leffers;Baukje-Nynke Hoogeboom;Ineke L. E. Hamming

Frequent Co-Authors

Jan Wilschut
Jan Wilschut University Medical Center Groningen
Gerrit L. Scherphof
Gerrit L. Scherphof University of Groningen
Harry Hollema
Harry Hollema University Medical Center Groningen
Anke Huckriede
Anke Huckriede University Medical Center Groningen
Maarten J. Postma
Maarten J. Postma University of Groningen
Cornelis J. M. Melief
Cornelis J. M. Melief ISA Pharmaceuticals (Netherlands)
Sjoerd H. van der Burg
Sjoerd H. van der Burg Leiden University Medical Center
Ed Schuuring
Ed Schuuring University Medical Center Groningen
Jan Kornelis Dijkstra
Jan Kornelis Dijkstra University of Groningen

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, exploring related healthcare degrees can open diverse career opportunities. Many professionals transition into nursing roles, and programs like online ABSN programs for non nurses provide an efficient pathway for individuals without prior nursing experience. These programs accelerate the learning curve and prepare students for impactful healthcare roles quickly.

Additionally, students seeking faster entry into nursing might consider accelerated nursing programs. These programs are designed to build clinical skills rapidly while maintaining strong academic standards, helping graduates advance in specialized fields related to Immunology and patient care.

Entry-level options like LPN programs easy to get into offer accessible routes to enter nursing, which can be a foundation for future specialization. Such programs often focus on practical skills and patient interaction, essential for immunological healthcare settings.

For advanced practice roles, exploring the easiest nurse practitioner program options can be beneficial. These programs train nurses to provide specialized care, including immunological assessments and treatments, offering a rewarding career trajectory in this dynamic field.

Best Scientists Citing Toos Daemen

Trending Scientists

Recently Published Articles